Humana New and Revised Medical Coverage Policies
December 2017 ~
Humana has released two new medical coverage policies and several updates to policies effective at the start of the New Year.
New Medical Coverage Policies
- Molecular diagnostic testing for vaginitis and sexually transmitted infections
- Recurrent pregnancy loss
Medical Coverage Policies with Significant Revisions
- Achalasia and gastroesophageal reflux disease (GERD) treatments Effective 1/1/18
- Breast reconstruction
- Chiropractic care
- Cochlear implants, auditory brainstem implants Effective 1/1/18
- Comparative genomic hybridization/chromosomal microarray analysis
- Fecal microbiota transplantation (FMT)
- Fusion imaging
- Gastric pacing
- Gastrointestinal (GI) motility monitoring
- Genetic testing for hereditary hemochromatosis
- Genetic testing for muscular dystrophy and spinal muscular atrophy
- Implantable infusion pumps for pain or spasticity Effective 1/1/18
- Infertility evaluation and treatments
- Intra-operative neurological monitoring
- Lymphedema – diagnosis and treatment
- Mobility assistive devices (wheelchairs) Effective 1/1/18
- Noninvasive prenatal screening
- Osteochondral defects surgery
- Pharmacogenomics and companion diagnostics
- Platelet-derived growth factors for wound healing
- Pneumatic compression pumps
- Rheumatoid arthritis: biologic markers and pharmacologic assessment
- Rhinoplasty/septoplasty
- Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
Full details on these changes can be found at Humana.com/provider by selecting “Medical and Pharmacy Coverage Policies” under “Resources.”
Source(s): YourPractice;